• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Obstet Gynecol . Risk of Severe Coronavirus Disease 2019 (COVID-19) in Pregnant and Postpartum Individuals After the Pandemic Emergency

tetano

Editor, Senior Moderator
Obstet Gynecol


. 2026 Jul 9.
doi: 10.1097/AOG.0000000000006364. Online ahead of print.
Risk of Severe Coronavirus Disease 2019 (COVID-19) in Pregnant and Postpartum Individuals After the Pandemic Emergency

Matthew M Coates[SUP] 1 [/SUP], Onyebuchi A Arah, Stacey L Rowe, Sheena G Sullivan, Flor M Muñoz, Annette K Regan


Affiliations
Abstract

Objective: To evaluate the risks of severe coronavirus disease 2019 (COVID-19)-related outcomes among pregnant and postpartum individuals and nonpregnant women during the Delta variant period and after the pandemic emergency ended in the United States.
Methods: We conducted a retrospective cohort study of 18- to 49-year-old women identified in a national U.S. commercial insurance claims database during the Delta variant (July 1-December 20, 2021) and postemergency periods (May 11, 2023-September 10, 2024). Pregnant and postpartum individuals unvaccinated for COVID-19 during the year before follow-up were propensity score-matched to four nonpregnant women. Primary outcomes were laboratory-confirmed or clinically diagnosed COVID-19 with subsequent COVID-19 hospitalization, pneumonia hospitalization, or a severe composite COVID-19 hospitalization such as acute respiratory failure, intensive care unit admission, acute respiratory distress syndrome, or respiratory support.
Results: Among the individuals followed during the Delta variant (1,109,384) and postemergency (878,003) periods, hospitalization rates with COVID-19 were substantially higher among pregnant individuals than among postpartum individuals or nonpregnant women. In propensity score-matched analyses, the risks of all primary outcomes were elevated for individuals who were pregnant during the Delta period, compared with matched nonpregnant women. Although absolute risks of severe COVID-19 outcomes were lower during the postemergency period, the relative risks (RRs) of COVID-19 hospitalization (RR 4.09; 95% CI, 3.65-4.59) and pneumonia hospitalization (RR 2.78; 95% CI, 1.38-4.81) during pregnancy remained elevated. The RR for severe composite COVID-19 hospitalization (RR 2.17; 95% CI, 0.35-6.67) was imprecise, reflecting substantial uncertainty. Risks for severe COVID-19-related outcomes were also elevated postpartum. Sensitivity analyses reinforced these findings.
Conclusion: Higher risks of severe COVID-19-related outcomes among pregnant and postpartum individuals have persisted since the resolution of the pandemic emergency.


 
Back
Top